Confirmation of the low clinical effect of human herpesvirus-6 and -7 infections after renal transplantation

Journal of Medical Virology

Volumn 84, Issue 3, 2012, Pages 450-456

  Caïola, Delphine ^a   Karras, Alexandre ^b   Flandre, Philippe ^c   Boutolleau, David ^a,d   Scieux, Catherine ^e   Agut, Henri ^a,d   Legendre, Christophe ^f   Gautheret Dejean, Agnès ^a,d,g  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c INSERM   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Antiviral prophylaxis; Graft rejection; Human cytomegalovirus; Human herpesvirus 6; Human herpesvirus 7; Immunosuppressive regimen; Renal transplantation; Viral load

Indexed keywords

ACICLOVIR; AMINOTRANSFERASE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN A; GAMMA GLUTAMYLTRANSFERASE; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY; VALACICLOVIR;

ACUTE GRAFT REJECTION; ADULT; AGED; ANTIVIRAL THERAPY; ARTICLE; BETAHERPESVIRINAE; BLOOD DONOR; CHOLESTASIS; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CONFUSION; CONTROLLED STUDY; CYTOLYSIS; CYTOLYTIC HEPATITIS; CYTOMEGALOVIRUS INFECTION; DELAYED GRAFT FUNCTION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; HALLUCINATION; HERPES SIMPLEX; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; KIDNEY FAILURE; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LOW DRUG DOSE; LYMPHOCYTE COUNT; MALE; NEUTROPENIA; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; PNEUMONIA; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PYREXIA IDIOPATHICA; VIRUS DETECTION; VIRUS REACTIVATION; VIRUS REPLICATION;

ADULT; AGED; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HERPESVIRUS 6, HUMAN; HERPESVIRUS 7, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ROSEOLOVIRUS INFECTIONS; TREATMENT OUTCOME; VIRAL LOAD; VIRUS REPLICATION; YOUNG ADULT;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 7;

EID: 84855870230     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23206     Document Type: Article

References (33)

1. Ablashi DV, Devin CL, Yoshikawa T, Lautenschlager I, Luppi M, Kuhl U, Komaroff AL. 2010. Review Part 3: Human herpesvirus-6 in multiple non-neurological diseases. J Med Virol 82: 1903-1910.
2. Acott PD, Lawen J, Lee S, Crocker JF. 2001. Basiliximab versus ATG/ALG induction in pediatric renal transplants: Comparison of herpes virus profile and rejection rates. Transplant Proc 33: 3180-3183.
3. Agut H, Aubin JT, Huraux JM. 1991. Homogeneous susceptibility of distinct human herpesvirus 6 strains to antivirals in vitro. J Infect Dis 163: 1382-1383.
4. Asano Y, Yoshikawa T, Suga S, Yazaki T, Kondo K, Yamanishi K. 1990. Fatal fulminant hepatitis in an infant with human herpesvirus-6 infection. Lancet 335: 862-863.
5. Black JB, Burns DA, Goldsmith CS, Feorino PM, Kite-Powell K, Schinazi RF, Krug PW, Pellett PE. 1997. Biologic properties of human herpesvirus 7 strain SB. Virus Res 52: 25-41.
6. Boutolleau D, Fernandez C, Andre E, Imbert-Marcille BM, Milpied N, Agut H, Gautheret-Dejean A. 2003. Human herpesvirus (HHV)-6 and HHV-7: Two closely related viruses with different infection profiles in stem cell transplantation recipients. J Infect Dis 187: 179-186.
7. Boutolleau D, Bonduelle O, Sabard A, Devers L, Agut H, Gautheret-Dejean A. 2005. Detection of human herpesvirus 7 DNA in peripheral blood reflects mainly CD4+ cell count in patients infected with HIV. J Med Virol 76: 223-228.
8. Brennan DC, Storch GA, Singer GG, Lee L, Rueda J, Schnitzler MA. 2000. The prevalence of human herpesvirus-7 in renal transplant recipients is unaffected by oral or intravenous ganciclovir. J Infect Dis 181: 1557-1561.
9. Cervera C, Marcos MA, Linares L, Roig E, Benito N, Pumarola T, Moreno A. 2006. A prospective survey of human herpesvirus-6 primary infection in solid organ transplant recipients. Transplantation 82: 979-982.
10. Chapenko S, Folkmane I, Tomsone V, Amerika D, Rozentals R, Murovska M. 2000. Co-infection of two beta-herpesviruses (CMV and HHV-7) as an increased risk factor for 'CMV disease' in patients undergoing renal transplantation. Clin Transplant 14: 486-492.
11. Chapenko S, Folkmane I, Ziedina I, Chistyakovs M, Rozentals R, Krumina A, Murovska M. 2009. Association of HHV-6 and HHV-7 reactivation with the development of chronic allograft nephropathy. J Clin Virol 46: 29-32.
12. Clark DA, Nacheva EP, Leong HN, Brazma D, Li YT, Tsao EH, Buyck HC, Atkinson CE, Lawson HM, Potter MN, Griffiths PD. 2006. Transmission of integrated human herpesvirus 6 through stem cell transplantation: Implications for laboratory diagnosis. J Infect Dis 193: 912-916.
13. DesJardin JA, Gibbons L, Cho E, Supran SE, Falagas ME, Werner BG, Snydman DR. 1998. Human herpesvirus 6 reactivation is associated with cytomegalovirus infection and syndromes in kidney transplant recipients at risk for primary cytomegalovirus infection. J Infect Dis 178: 1783-1786.
14. Fernandez C, Boutolleau D, Manichanh C, Mangeney N, Agut H, Gautheret-Dejean A. 2002. Quantitation of HHV-7 genome by real-time polymerase chain reaction assay using MGB probe technology. J Virol Methods 106: 11-16.
15. Galarraga MC, Gomez E, de Ona M, Rodriguez A, Laures A, Boga JA, Melon S. 2005. Influence of ganciclovir prophylaxis on cytomegalovirus, human herpesvirus 6, and human herpesvirus 7 viremia in renal transplant recipients. Transplant Proc 37: 2124-2126.
16. Gautheret-Dejean A, Manichanh C, Thien-Ah-Koon F, Fillet AM, Mangeney N, Vidaud M, Dhedin N, Vernant JP, Agut H. 2002. Development of a real-time polymerase chain reaction assay for the diagnosis of human herpesvirus-6 infection and application to bone marrow transplant patients. J Virol Methods 100: 27-35.
17. Hidaka Y, Okada K, Kusuhara K, Miyazaki C, Tokugawa K, Ueda K. 1994. Exanthem subitum and human herpesvirus 7 infection. Pediatr Infect Dis J 13: 1010-1011.
18. Kidd IM, Clark DA, Sabin CA, Andrew D, Hassan-Walker AF, Sweny P, Griffiths PD, Emery VC. 2000. Prospective study of human betaherpesviruses after renal transplantation: Association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation 69: 2400-2404.
19. Koukourgianni F, Pichault V, Liutkus A, Gillet Y, Ranchin B, Mestrallet G, Cochat P. 2009. HHV-6 infection in a pediatric kidney transplant patient. Pediatr Nephrol 24: 2445-2448.
20. Laurendeau I, Bahuau M, Vodovar N, Larramendy C, Olivi M, Bieche I, Vidaud M, Vidaud D. 1999. TaqMan PCR-based gene dosage assay for predictive testing in individuals from a cancer family with INK4 locus haploinsufficiency. Clin Chem 45: 982-986.
21. Lawrence GL, Chee M, Craxton MA, Gompels UA, Honess RW, Barrell BG. 1990. Human herpesvirus 6 is closely related to human cytomegalovirus. J Virol 64: 287-299.
22. Ljungman P, Singh N. 2006. Human herpesvirus-6 infection in solid organ and stem cell transplant recipients. J Clin Virol 37: S87-S91.
23. Lowance D, Neumayer HH, Legendre CM, Squifflet JP, Kovarik J, Brennan PJ, Norman D, Mendez R, Keating MR, Coggon GL, Crisp A, Lee IC. 1999. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med 340: 1462-1470.
24. Najioullah F, Thouvenot D, Lina B. 2001. Development of a real-time PCR procedure including an internal control for the measurement of HCMV viral load. J Virol Methods 92: 55-64.
25. Okuno T, Higashi K, Shiraki K, Yamanishi K, Takahashi M, Kokado Y, Ishibashi M, Takahara S, Sonoda T, Tanaka K, Baba K, Yabuuchi H, Kurata T. 1990. Human herpesviruses 6 infection in renal transplantation. Transplantation 49: 519-522.
26. Osman HK, Peiris JS, Taylor CE, Warwicker P, Jarrett RF, Madeley CR. 1996. "Cytomegalovirus disease" in renal allograft recipients: Is human herpesvirus 7 a co-factor for disease progression? J Med Virol 48: 295-301.
27. Razonable RR, Brown RA, Humar A, Covington E, Alecock E, Paya CV. 2005. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis 192: 1331-1339.
28. Tong CY, Bakran A, Williams H, Cheung CY, Peiris JS. 2000. Association of human herpesvirus 7 with cytomegalovirus disease in renal transplant recipients. Transplantation 70: 213-216.
29. Wade AW, McDonald AT, Acott PD, Lee S, Crocker JF. 1998. Human herpes virus-6 or Epstein-Barr virus infection and acute allograft rejection in pediatric kidney transplant recipients: Greater risk for immunologically naive recipients. Transplant Proc 30: 2091-2093.
30. Yalcin S, Karpuzoglu T, Suleymanlar G, Mutlu G, Mukai T, Yamamoto T, Isegawa Y, Yamanishi K. 1994. Human herpesvirus 6 and human herpesvirus 7 infections in renal transplant recipients and healthy adults in Turkey. Arch Virol 136: 183-190.
31. Yamanishi K, Okuno T, Shiraki K, Takahashi M, Kondo T, Asano Y, Kurata T. 1988. Identification of human herpesvirus-6 as a causal agent for exanthem subitum. Lancet ii: 1065-1067.
32. Yoshikawa T, Asano Y. 2000. Central nervous system complications in human herpesvirus-6 infection. Brain Dev 22: 307-314.
33. Yoshikawa T, Suga S, Asano Y, Nakashima T, Yazaki T, Ono Y, Fujita T, Tsuzuki K, Sugiyama S, Oshima S. 1992. A prospective study of human herpesvirus-6 infection in renal transplantation. Transplantation 54: 879-883.